Abstract
Recurrent brief depression (RBD) fulfills DSM-III-R symptom criteria for major depression but the episodes are of shorter duration than the 2 weeks required by DSM-III-R. The clinical importance of the disorder has been observed in prophylactic studies of suicidal bahavior. The possibility that antidepressants with selective action on the reuptake of serotonin might be effective in preventing recurrences of brief depression has been investigated. Fluoxetine in a dose of 120 mg a week, administered biweekly, had no effect on the recurrence rate, which was maintained at approximately the same rate on fluoxetine (1 every 18.7 days) as with placebo (1 every 17.6 days). In a group of patients with two or more prior episodes of suicidal behavior, there were 18 attempted suicides in the 54 patients treated with fluoxetine and the same number in the 53 patients treated with placebo. Fluoxetine neither raised nor lowered the suicide attempt rate as compared with placebo, providing no evidence to support the drug's role in either suicide provocation or prevention. Since fluoxetine is clearly effective with recurrent major depression, it would appear that recurrent brief depression has a different pharmacology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM-III). APA, Washington
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R). APA, Washington
Angst J, (1990) Recurrent brief depression: A new concept of depression. Pharmacopsychiatr 23:63–66
Angst J, Dobler-Mikola A (1985) The Zurich study: A prospective epidemiological study of depressive, neurotic and psychomatic syndromes. IV Recurrent and nonrecurrent brief depression. Eur Arch Psychiatr Neur Sci 234:408–416
Angst J, Merinkangas K, Scheidegger P (1990) Recurrent brief depression: A new subtype of affective disorder. J Affect Disord 19:87–98
Beasley CM, Dornseif BE, Bosomworth JC (1991) Fluoxetine and suicidality: absence of association in controlled depression trials. Br Med J 303:685–692
Feighner JP, Robins E, Guze SB (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57–63
Gregory MS (1915) Transient attacks of manic-depressive insanity. Med Rec 88:1040
Lepine JP, Weill CF, Boyer P, Payan C, Lecrubier Y (1994) The comorbidity of RBD depression and anxiety in primary care patients. Eur Arch Psychiatr Neur Sci
Maier W, Herr R, Gansicke M, Lichtermann D, Houshang K, Benkert O (1994) Recurrent brief depression in general practice: Clinical features, comorbidity with other disorders, and needs for treatment. Eur Arch Psychiatr Neur Sci
Montgomery SA (1989) The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 4 (suppl 1):113–119
Montgomery SA (1992) The advantages of paroxetine in different subgroups of depression. Int Clin Psychopharmacol 6 (S 4):91–100
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Montgomery SA, Dufour H, Brion S, Gailledreau J, Lequeille X, Ferrey G, Moron P, Parant-Lucena N, Singer L, Danion JM, Beuzen JM, Pierredoin MA (1988) The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 153 (suppl 3):69–76
Montgomery SA, McAulay R, Rani SJ, Roy D, Montgomery DB (1981) A double blind comparison of zimelidine and amitriptyline in endogenous depression. Acta Psychiatr Scand 63 (suppl. 290):314–327
Montgomery SA, Montgomery DB (1992) Prophylactic treatment in recurrent unipolar depression. In: Montgomery SA, Rouillon F (eds) Long Term Treatment of Depression. John Wiley & Sons. Chichester, pp 53–80
Montgomery SA, Montgomery DB, Baldwin D, Green M (1990) The duration, nature and recurrence rate of brief depressions. Neuro-Psychopharmacol Biol Psychiatry 14:729–735
Montgomery SA, Montgomery DB, Evans R (1993) Pharmacological differences between brief and major depressions. Eur Neuropsychopharmacol 3 (suppl 3):214–215 (Abstract)
Montgomery SA, Montgomery, DB, Green M, Baldwin D (1989) Intermittent 3-day depressions and suicidal behaviour. Neuropsychobiology 22:128–134
Montgomery SA, Montgomery DB, Rani J, et al. (1979) Maintenance therapy in repeat suicidal behaviour: a placebo controlled trial. In: Proceedings 10th International Congress for Suicide Prevention and Crisis Intervention. Ottawa, pp 227–229
Montgomery SA, Roy D, Montgomery DB (1983) The prevention of recurrent suicidal acts. Br J Clin Pharmacol 15:183S-188S
Paskind HA (1929) Brief attacks of manic-depressive depression. Arch Neurol Psych 22:123–134
Rosenbaum JF, Quitkin FM, Fava M, Amsterdam JD, Fawcett J. Zajecka J, Lebegue BJ, Reimherr FW, Beasley CM (1993) Fluoxetine vs placebo: long-term treatment of MDD. American College of Neuropsychopharmacology 32 Annual Meeting: (Abstract)
Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria (RDC) for a selected group of functional disorders. New York State psychiatric Institute, New York
Stark P, Hardison CD (1985) A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiat 46:53–58
Teicher MH, Glod C, Cole JO (1990) The emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147:207–210
Wakelin JS (1988) The role of serotonin in depression and suicide: do serotonin reuptake inhibitors provide a key? Adv Biol Psychiatry 17:70–83
World Health Organisation (1992) International classification of diseases 10th revision (ICD-10). World Health Organisation, Geneva
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Montgomery, D.B., Roberts, A., Green, M. et al. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Nuerosci 244, 211–215 (1994). https://doi.org/10.1007/BF02190400
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02190400